Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases.

Cancers (Basel) · 2022 · PMC9775484 · PMID 36551527

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Conclusions SMART for liver metastases has highly significant dosimetric benefits with increased PTV coverage and reduced maximum doses in OAR.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.